MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Earnings Estimates
NASDAQ:MDGL • US5588681057
432 USD
-13.85 (-3.11%)
At close: Feb 27, 2026
432 USD
0 (0%)
After Hours: 2/27/2026, 8:17:29 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 180.133M | 958.403M 432.05% | 1.483B 54.74% | 2.161B 45.72% | 2.99B 38.36% | 4.022B 34.52% | 4.94B 22.82% | 5.449B 10.30% | 6.134B 12.57% | 6.025B -1.78% | ||
| EBITDA YoY % growth | -379.969M -29.62% | -496.779M -30.74% | -298.591M 39.89% | -170.473M 42.91% | 377.35M 321.36% | 918.14M 143.31% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -380.496M -29.60% | -497.875M -30.85% | -300.097M 39.72% | -92.919M 69.04% | 373.95M 502.45% | 941.5M 151.77% | 1.914B 103.29% | 2.745B 43.42% | 3.251B 18.43% | 3.83B 17.81% | 3.664B -4.33% | |
| Operating Margin | N/A | -276.39% | -31.31% | -6.27% | 17.30% | 31.49% | 47.59% | 55.57% | 59.66% | 62.44% | 60.81% | |
| EPS YoY % growth | -19.94 -15.73% | -22.11 -10.88% | -12.75 42.33% | 1.05 108.25% | 17.85 1,596.75% | 38.24 114.18% | 57.53 50.46% | 76.00 32.11% | 134.04 76.37% | 166.79 24.43% | 187.67 12.52% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.39 -2.13% | -0.63 66.63% | 1.13 122.77% | 1.99 177.45% | 5.37 258.23% | 8.58 1,452.97% | 11.33 903.00% | 14.10 608.51% |
| Revenue Q2Q % growth | 309.16M 125.25% | 356.17M 67.37% | 396.41M 37.99% | 435.99M 35.79% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -97.92M -24.06% | -69.457M -49.54% | 35.953M 131.86% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -78.058M 1.58% | -20.734M 56.07% | 28.048M 124.61% | 53.792M 190.24% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -2.57 5.17% | -0.69 | -1.88 | -274.00% |
| Q3 2025 Q2Q % growth | -4.96 -0.81% | -2.12 | -2.84 | -133.61% |
| Q2 2025 Q2Q % growth | -1.90 73.24% | -3.71 | 1.81 | 48.79% |
| Q1 2025 Q2Q % growth | -3.32 55.01% | -3.84 | 0.52 | 13.46% |
| Q4 2024 Q2Q % growth | -2.71 52.29% | -4.33 | 1.62 | 37.40% |
| Q3 2024 Q2Q % growth | -4.92 7.87% | -7.05 | 2.13 | 30.22% |
| Q2 2024 Q2Q % growth | -7.10 -51.39% | -7.68 | 0.58 | 7.50% |
| Q1 2024 Q2Q % growth | -7.38 -74.47% | -6.41 | -0.97 | -15.12% |
| Q4 2023 Q2Q % growth | -5.68 -14.06% | -5.39 | -0.29 | -5.38% |
| Q3 2023 Q2Q % growth | -5.34 -12.42% | -5.02 | -0.32 | -6.30% |
| Q2 2023 Q2Q % growth | -4.69 -13.29% | -4.67 | -0.02 | -0.37% |
| Q1 2023 Q2Q % growth | -4.23 -25.89% | -5.04 | 0.81 | 16.00% |
| Q4 2022 Q2Q % growth | -4.98 -31.75% | -4.65 | -0.33 | -7.16% |
| Q3 2022 Q2Q % growth | -4.75 -25.33% | -4.24 | -0.51 | -12.11% |
| Q2 2022 Q2Q % growth | -4.14 -11.29% | -3.77 | -0.37 | -9.78% |
| Q1 2022 Q2Q % growth | -3.36 -1.20% | -3.69 | 0.33 | 9.02% |
| Q4 2021 Q2Q % growth | -3.78 1.05% | -3.95 | 0.17 | 4.41% |
| Q3 2021 Q2Q % growth | -3.79 -1.07% | -3.98 | 0.19 | 4.67% |
| Q2 2021 Q2Q % growth | -3.72 -16.98% | -3.66 | -0.06 | -1.75% |
| Q1 2021 Q2Q % growth | -3.32 -41.88% | -3.92 | 0.60 | 15.32% |
| Q4 2020 Q2Q % growth | -3.82 | -3.93 | 0.11 | 2.85% |
| Q3 2020 Q2Q % growth | -3.75 | -3.36 | -0.39 | -11.47% |
| Q2 2020 Q2Q % growth | -3.18 | -2.50 | -0.68 | -27.07% |
| Q1 2020 Q2Q % growth | -2.34 | -1.98 | -0.36 | -18.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 321.083M 210.77% | 318.74M | 2.343M | 0.74% |
| Q3 2025 Q2Q % growth | 287.268M 362.03% | 252.25M | 35.018M | 13.88% |
| Q2 2025 Q2Q % growth | 212.802M 1,353.76% | 165.56M | 47.242M | 28.53% |
| Q1 2025 Q2Q % growth | 137.25M | 116.1M | 21.15M | 18.22% |
| Q4 2024 Q2Q % growth | 103.32M | 100.53M | 2.79M | 2.78% |
| Q3 2024 Q2Q % growth | 62.175M | 34.873M | 27.302M | 78.29% |
| Q2 2024 Q2Q % growth | 14.638M | 3.981M | 10.657M | 267.70% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 12.8% | 47.32% | -1.6% | -14.43% |
| Revenue | 0.72% | 0.27% | 0.42% | 8.46% |